Antiparasitic chemotherapy: from genomes to mechanisms

David Horn, Manoj T. Duraisingh

    Research output: Contribution to journalArticle

    34 Citations (Scopus)

    Abstract

    Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance, the development of novel antiparasitic chemotherapies remains of major importance for disease control. A better understanding of drug transport (uptake and efflux), drug metabolism and the identification of drug targets, and mechanisms of drug resistance would facilitate the development of more effective therapies. Here, we focus on malaria and African trypanosomiasis. We review existing drugs and drug development, emphasizing high-throughput genomic and genetic approaches, which hold great promise for elucidating antiparasitic mechanisms. We describe the approaches and technologies that have been influential for each parasite and develop new ideas for future research directions, including mode-of-action studies for drug target deconvolution.
    Original languageEnglish
    Pages (from-to)71-94
    Number of pages24
    JournalAnnual Review of Pharmacology and Toxicology
    Volume54
    Early online date11 Sep 2013
    DOIs
    Publication statusPublished - Jan 2014

    Fingerprint

    Antiparasitic Agents
    Chemotherapy
    Genes
    Genome
    Drug Therapy
    Pharmaceutical Preparations
    Drug Resistance
    African Trypanosomiasis
    Disease control
    Malaria
    Parasites
    Deconvolution
    Vaccines
    Metabolism
    Technology
    Throughput

    Cite this

    @article{71f0021daf70446a9d0fcbb3dcf65658,
    title = "Antiparasitic chemotherapy: from genomes to mechanisms",
    abstract = "Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance, the development of novel antiparasitic chemotherapies remains of major importance for disease control. A better understanding of drug transport (uptake and efflux), drug metabolism and the identification of drug targets, and mechanisms of drug resistance would facilitate the development of more effective therapies. Here, we focus on malaria and African trypanosomiasis. We review existing drugs and drug development, emphasizing high-throughput genomic and genetic approaches, which hold great promise for elucidating antiparasitic mechanisms. We describe the approaches and technologies that have been influential for each parasite and develop new ideas for future research directions, including mode-of-action studies for drug target deconvolution.",
    author = "David Horn and Duraisingh, {Manoj T.}",
    year = "2014",
    month = "1",
    doi = "10.1146/annurev-pharmtox-011613-135915",
    language = "English",
    volume = "54",
    pages = "71--94",
    journal = "Annual Review of Pharmacology and Toxicology",
    issn = "0362-1642",
    publisher = "Annual Reviews",

    }

    Antiparasitic chemotherapy : from genomes to mechanisms. / Horn, David; Duraisingh, Manoj T.

    In: Annual Review of Pharmacology and Toxicology, Vol. 54, 01.2014, p. 71-94.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Antiparasitic chemotherapy

    T2 - from genomes to mechanisms

    AU - Horn, David

    AU - Duraisingh, Manoj T.

    PY - 2014/1

    Y1 - 2014/1

    N2 - Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance, the development of novel antiparasitic chemotherapies remains of major importance for disease control. A better understanding of drug transport (uptake and efflux), drug metabolism and the identification of drug targets, and mechanisms of drug resistance would facilitate the development of more effective therapies. Here, we focus on malaria and African trypanosomiasis. We review existing drugs and drug development, emphasizing high-throughput genomic and genetic approaches, which hold great promise for elucidating antiparasitic mechanisms. We describe the approaches and technologies that have been influential for each parasite and develop new ideas for future research directions, including mode-of-action studies for drug target deconvolution.

    AB - Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance, the development of novel antiparasitic chemotherapies remains of major importance for disease control. A better understanding of drug transport (uptake and efflux), drug metabolism and the identification of drug targets, and mechanisms of drug resistance would facilitate the development of more effective therapies. Here, we focus on malaria and African trypanosomiasis. We review existing drugs and drug development, emphasizing high-throughput genomic and genetic approaches, which hold great promise for elucidating antiparasitic mechanisms. We describe the approaches and technologies that have been influential for each parasite and develop new ideas for future research directions, including mode-of-action studies for drug target deconvolution.

    UR - http://www.scopus.com/record/display.uri?eid=2-s2.0-84891890241&origin=resultslist&sort=plf-f&src=s&st1=Antiparasitic+chemotherapy%3a+from+genomes+to+mechanisms+&st2=&sid=C080050AA99C084412ABF7ECFDDD1519.fM4vPBipdL1BpirDq5Cw%3a970&sot=b&sdt=b&sl=70&s=TITLE-ABS-KEY%28Antiparasitic+chemotherapy%3a+from+genomes+to+mechanisms+%29&relpos=0&citeCnt=7&searchTerm=

    U2 - 10.1146/annurev-pharmtox-011613-135915

    DO - 10.1146/annurev-pharmtox-011613-135915

    M3 - Article

    C2 - 24050701

    VL - 54

    SP - 71

    EP - 94

    JO - Annual Review of Pharmacology and Toxicology

    JF - Annual Review of Pharmacology and Toxicology

    SN - 0362-1642

    ER -